EPZM logo

Epizyme (EPZM) Shareholders Equity

Annual Shareholders Equity

-$20.69 M
-$205.59 M-111.19%

December 31, 2021


Summary


Performance

EPZM Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherEPZMbalance sheetmetrics:

Quarterly Shareholders Equity

-$20.28 M
-$31.40 M-282.37%

June 30, 2022


Summary


Performance

EPZM Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherEPZMbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

EPZM Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-111.2%-130.0%
3 y3 years-108.9%-106.2%
5 y5 years-108.8%-113.5%

EPZM Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat low-282.4%+2.0%
5 y5-year-106.2%at low-106.0%+2.0%
alltimeall time-106.2%+147.1%-105.5%+152.1%

Epizyme Shareholders Equity History

DateAnnualQuarterly
Jun 2022
-
-$20.28 M(-282.4%)
Mar 2022
-
$11.12 M(-153.8%)
Dec 2021
-$20.69 M(-111.2%)
-$20.69 M(-234.5%)
Sep 2021
-
$15.38 M(-77.3%)
Jun 2021
-
$67.63 M(-45.0%)
Mar 2021
-
$123.03 M(-33.5%)
Dec 2020
$184.90 M(-44.2%)
$184.90 M(-24.3%)
Sep 2020
-
$244.41 M(-16.7%)
Jun 2020
-
$293.36 M(-13.8%)
Mar 2020
-
$340.32 M(+2.8%)
Dec 2019
$331.14 M(+42.1%)
$331.14 M(+12.7%)
Sep 2019
-
$293.74 M(-9.8%)
Jun 2019
-
$325.69 M(-11.6%)
Mar 2019
-
$368.35 M(+58.1%)
Dec 2018
$233.01 M(-1.0%)
$233.01 M(+35.6%)
Sep 2018
-
$171.83 M(-16.4%)
Jun 2018
-
$205.58 M(-11.1%)
Mar 2018
-
$231.13 M(-1.8%)
Dec 2017
$235.37 M
$235.37 M(-12.2%)
Sep 2017
-
$268.19 M(+78.7%)
DateAnnualQuarterly
Jun 2017
-
$150.04 M(-14.0%)
Mar 2017
-
$174.52 M(-13.5%)
Dec 2016
$201.70 M(+19.0%)
$201.70 M(-13.7%)
Sep 2016
-
$233.80 M(-8.4%)
Jun 2016
-
$255.16 M(-8.5%)
Mar 2016
-
$279.01 M(+64.6%)
Dec 2015
$169.53 M(+5.8%)
$169.53 M(-10.6%)
Sep 2015
-
$189.55 M(-9.3%)
Jun 2015
-
$208.91 M(-4.3%)
Mar 2015
-
$218.37 M(+36.2%)
Dec 2014
$160.28 M(+53.7%)
$160.28 M(-7.2%)
Sep 2014
-
$172.75 M(-8.9%)
Jun 2014
-
$189.60 M(-5.5%)
Mar 2014
-
$200.64 M(+92.3%)
Dec 2013
$104.31 M(-304.0%)
$104.31 M(+19.5%)
Sep 2013
-
$87.28 M(-9.2%)
Jun 2013
-
$96.13 M(+433.0%)
Mar 2013
-
$18.04 M(-135.3%)
Dec 2012
-$51.13 M(+1.0%)
-$51.13 M
Dec 2011
-$50.64 M
-

FAQ

  • What is Epizyme annual stockholders equity?
  • What is the all time high annual shareholders equity for Epizyme?
  • What is Epizyme annual shareholders equity year-on-year change?
  • What is Epizyme quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Epizyme?
  • What is Epizyme quarterly shareholders equity year-on-year change?

What is Epizyme annual stockholders equity?

The current annual shareholders equity of EPZM is -$20.69 M

What is the all time high annual shareholders equity for Epizyme?

Epizyme all-time high annual stockholders equity is $331.14 M

What is Epizyme annual shareholders equity year-on-year change?

Over the past year, EPZM annual stockholders equity has changed by -$205.59 M (-111.19%)

What is Epizyme quarterly stockholders equity?

The current quarterly shareholders equity of EPZM is -$20.28 M

What is the all time high quarterly shareholders equity for Epizyme?

Epizyme all-time high quarterly stockholders equity is $368.35 M

What is Epizyme quarterly shareholders equity year-on-year change?

Over the past year, EPZM quarterly stockholders equity has changed by -$87.91 M (-129.99%)